Osteoarthritis, the most common form of arthritis, is primarily caused by wear and tear on the protective layer of cartilage ...

Long acting injection Fluticasone promising in knee osteoarthritis suggests a new study published in the The Lancet ...

A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current ...

Enlivex (ENLV) has released an update. Enlivex Therapeutics has commenced the next phase of its Allocetra trial, enrolling and dosing the first ...

Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of ...

There is no cure for knee osteoarthritis, but treatments can help relieve symptoms and improve quality of life. Knee osteoarthritis is one of the most common types of arthritis (the swelling and ...

Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent ...

Knee osteoarthritis treatments are challenging due to pain and joint structure variability. Lorecivivint (LOR) is an ...

Medications like Ozempic and Wegovy, which are used to treat type 2 diabetes and boost weight loss, may also help reduce knee ...

Subcutaneous semaglutide is currently marketed under the brand name Wegovy for chronic weight management and to reduce the risk of major adverse cardiovascular events in adults with established ...

Organogenesis (ORGO) announced the favorable outcome of the interim analysis of its second Phase 3 randomized control trial of ReNu, a ...

“Among participants with obesity and knee osteoarthritis with moderate-to-severe pain, treatment with once-weekly injectable ...